HIV-1 integrase inhibitory substances from Coleus parvifolius

Phytotherapy Research

Volumn 17, Issue 3, 2003, Pages 232-239

  Tewtrakul, Supinya ^a   Miyashiro, Hirotsugu ^a   Nakamura, Norio ^a   Hattori, Masao ^a   Kawahata, Takuya ^b   Otake, Toru ^b   Yoshinaga, Tomokazu ^c   Fujiwara, Tamio ^c   Supavita, Tanomjit ^d   Yuenyongsawad, Supreeya ^d   Rattanasuwon, Pranee ^d   Dej Adisai, Sukanya ^d  

^a UNIVERSITY OF TOYAMA   (Japan)

^b OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^c SHIONOGI AND CO LTD   (Japan)

^d NONE

Author keywords

Anti HIV activity; Coleus parvifolius; HIV 1; Inhibition; Integrase; Rosmarinic acid derivatives; Thai plants

Indexed keywords

5 O BETA DEXTRO GLUCOPYRANOSYLLUTEOLIN 7 METHYL ETHER; ALCOHOL; ALPHA AMYRIN; BETA AMYRIN; COLEUS PARVIFOLIUS EXTRACT; DAUCOSTEROL; INTEGRASE; LUTEOLIN; LUTEOLIN 5 O BETA DEXTRO GLUCOPYRANOSIDE; LUTEOLIN 5 O BETA DEXTRO GLUCURONIDE; LUTEOLIN 7 GLUCOSIDE; PHYTOL; PLANT EXTRACT; ROSMARINIC ACID; ROSMARINIC ACID METHYL ESTER; UNCLASSIFIED DRUG; WATER;

ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DETERMINATION; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IC 50; NONHUMAN; PLANT; STRUCTURE ANALYSIS; THAILAND;

ANTI-HIV AGENTS; COLEUS; FLOWERS; FRUIT; HIV INTEGRASE; HIV-1; HUMANS; MEDICINE, TRADITIONAL; MICROBIAL SENSITIVITY TESTS; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; PLANT ROOTS; SEEDS; THAILAND; TUMOR CELLS, CULTURED;

COLEUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0037357211     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.1111     Document Type: Article

References (43)

1. Agrawal PK. 1989. Carbon-13 NMR of Flavonoids. Elsevier: Amsterdam.
2. Arda N, Goren N, Kuru A, et al. 1997. Saniculoside N from Sanicula europaea L. J Nat Prod 60: 1170-1173.
3. Auf'mkolk M, Amir SM, Kubota K, Ingbar SH. 1985. The active principles of plant extracts with antithyrotropic activity: oxidation products of derivatives of 3,4-dihydroxycinnamic acid. Endocrinology 116: 1677-1686.
4. Borman AM, Paulous S, Clavel F. 1996. Resistance of human immunodeficiency virus type 1 to protease inhibitors: Selection of resistance mutations in the presence and absence of the drug. J Gen Virol 77: 419-426.
5. Burke CJ, Sanyal G, Bruner MW, et al. 1992. Structural implications of spectroscopic characterization of putative zinc-finger peptide from HIV-1 integrase. J Biol Chem 267: 9639-9644.
6. Chang YC, Ching TT, Syn W. 1996. Assaying the activity of HIV-1 integrase with DNA-coated plates. J Virol Methods 59: 135-140.
7. Chen CP, Yokozawa T, Chung HY. 1999. Inhibitory effect of caffeic acid analogues isolated from Salviae Miltiorrhizae Radix against 1,1-diphenyl-2-picrylhydrazyl radical. Exp Toxicol Pathol 51: 59-63.
8. Elfarrash MA, Kuroda MJ, Kitazaki T, et al. 1994. Generation and characterization of a human-immunodeficiency-virus type 1 (HIV-1) mutant resistant to an HIV-1 protease inhibitor. J Virol 68: 233-239.
9. Englberger W, Hadding U, Etschenberg E, et al. 1988. Rosmarinic acid: a new inhibitor of complement C3-convertase with anti-inflammatory activity. Int J Immunopharmacol 10: 729-737.
10. Evans WC. 1989. Trease and Evans' Pharmacognosy, 13th edition. Bailliere Tindall: London.
11. Fesen M, Pommier Y, Leteurtre F, et al. 1994. Inhibition of HIV-1 integrase by flavones, caffeic acid phenyl ester and related compounds. Biochem. Pharmacol 48: 595-608.
12. Fujiwara T, Mizuuchi K. 1988. Retroviral DNA integration: Structure of an integrase intermediate. Cell 54: 497-504.
13. Goldgur Y, Craigie R, Cohen GH, et al. 1999. Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: A platform for antiviral drug design. Proc Natl Acad Sci USA 96: 13040-13043.
14. Harada S, Koyanagi Y, Yamamoto N. 1985. Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229: 563-566.
15. Harborne JB, Agrawal, PK, Bansal MC. 1988. The Flavonoids (Advances in Research since 1980). Chapman and Hall: London; 303-324.
16. Hase K, Kasimu R, Basnet P, et al. 1996. Preventive effect of lithospermate B from Salvia miltiorrhiza on experimental hepatitis induced by carbon tetrachloride or D-galactosamine/ lipopolysaccharide. Planta Med 63: 22-26.
17. Hazuda DJ, Hastings JC, Wolfe AC, Emini EA. 1994. A novel assay for the DNA strand-transfer reaction of HIV-1 integrase. Nucleic Acids Res 22: 1121-1122.
18. Hirsch MS, Conway B, D'Aquila RT. 1998. Antiretroviral drug resistance testing in adults with HIV infection. JAMA 279: 1984-1991.
19. Kamata K, Noguchi M, Nagai M. 1994. Hypotensive effects of lithospermate B isolated from the extract of Salviae Miltiorrhizae Radix in rats. Gen Pharmacol 25: 69-73.
20. Kasimu R, Tanaka K, Tezuka Y, et al. 1998. Comparative study of seventeen Salvia plants: aldose reductase inhibitory activity of water and MeOH extracts and liquid chromatographymass spectrometry (LC-MS) analysis of water extracts. Chem Pharm Bull 46: 500-504.
21. Katz RA, Skalka AM. 1994. The retroviral enzymes. Annu Rev Biochem 63: 133-173.
22. King PJ, Ma G, Miao W, et al. 1999. Structure-activity relationships: analogues of the dicaffeoyl quinic and dicaffeoyl tartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication. J Med Chem 42: 497-509.
23. Kuhnt M, Probstle A, Rimpler H, et al. 1995. Biological and pharmacological activities and further constituents of Hyptis verticillata. Planta Med 61: 227-232.
24. Kuhnt M, Rimpler H, Heinrich M. 1994. Lignans and other compounds from Mixe Indian medicinal plant, Hyptis verticella. Planta Med 36: 485-489.
25. Kraut L, Mues R, Speicher A, et al. 1996. Carboxylated α-pyrone derivatives and flavonoids from the liverwort Dumoritiera hirsuta. Phytochemistry 42: 1693-1698.
26. Lamaison JL, Petitjean-Fregtet C, Carnet A. 1990. Rosmarinic acid, total hydroxycinnamic derivatives and antioxidant activity of Apiaceae, Boraginaceae and Lamiaceae medicinals. Ann Pharm Fr 48: 103-108.
27. Liang HR, Vuorela P, Vuorela H, Hiltunen R. 1997. Isolation and immunomodulatory effect of flavonol glycosides from Epimedium hunanense. Planta Med 63: 316-319.
28. Lim YA, Kojima S, Nakamura N, et al. 1997. Inhibitory effects of Cordia spinensis extracts and their constituents on reverse transcriptase and protease from human immunodeficiency virus. Phytother Res 11: 490-495.
29. Lin Z, Neamati N, Zhao H, et al. 1999. Chicoric acid analogues as HIV-1 integrase inhibitors. J Med Chem 42: 1401-1414.
30. Makino T, Ono T, Muso E, Honda G. 1998. Inhibitory effect of Perilla frutescens and its phenolic constituents on cultured murine mesangial cell proliferation. Planta Med 64: 541-545.
31. Mazumder A, Wang S, Neamati N, et al. 1996. Antiviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease. J Med Chem 39: 2472-2481.
32. Mazumder A, Neamati N, Sunder S, et al. 1997. Curcumin analogs with altered potencies against HIV-1 integrase probes for biochemical mechanisms of drug action. J Med Chem 40: 3057-3063.
33. Neamati N, Hong H, Owen JM, et al. 1998. Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site. J Med Chem 41: 3202-3209.
34. Neamati N, Mazumder A, Zhao H, et al. 1997. Diarylsulfones, a novel class of human immunodeficiency virus type 1 integrase inhibitors. Antimicrob Agents Chemother 41: 385-393.
35. Otake T, Mori H, Morimoto M, et al. 1995. Screening of Indonesian plant extracts for anti-human immunodeficiency virus type 1 (HIV-1) activity. Phytother Res 9: 6-10.
36. Pieroni A, Pachaly P. 2000. Isolation and structure elucidation of ligustroflavone, a new apigenin triglycoside from the leaves of Ligustrum vulgare L. Pharmazie 55: 78-80.
37. Reddy MVR, Rao MR, Rhodes D, et al. 1999. Lamellarin α 20-sulfate, an inhibitor of HIV-1 integrase active against HIV-1 virus. J Med Chem 42: 1901-1907.
38. Robinson WE, Cordeiro M, Abdel-Malek S, et al. 1996. Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: Inhibition of the core catalytic domain of human immunodeficiency virus integrase. Mol Pharmacol 50: 846-855.
39. Sanchez de Rojas VR, Somoza B, Ortega T, Villar AM. 1996. Isolation and vasodilatory active flavonoids from the traditional remedy Satureja obovata. Planta Med 63: 316-319.
40. St-Clair MH, Martin JL, Tudor-Williams G, et al. 1991. Resistance to DDI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase. Science 253: 1557-1559.
41. Vink C, Banks M, Bethell R, Plasterk RHA. 1994. A high-throughput non-radioactive plate assay for activity of human immunodeficiency virus integrase protein. Nucleic Acids Res 22: 2176-2177.
42. Vink C, Plasterk RHA. 1993. The human immunodeficiency virus integrase protein. Trends Genet 9: 433-437.
43. Wainberg MA. 1998. Public health implications of antiretroviral therapy and HIV drug resistance. JAMA 279: 1977-1983.